Overview

Certain therapies may improve physical and psychosocial outcomes in patients with Crohn’s Disease. Among these therapies, clinical hypnosis may improve physical and psychosocial outcomes. This clinical trial studies the effectiveness of clinical hypnosis in children and adolescents. They are believed to be excellent candidates for clinical hypnosis because of their imaginations. Hypnosis is effective in minimizing abdominal pain, irritable bowel syndrome, anxiety, chronic pain, and stress from medical procedures in adults. However, no studies have been conducted on its effectiveness for children.

Study Information

This interventional study divides participants into two groups at random: the intervention group and the control group. The intervention group participates in an in-person session of clinical hypnosis, followed by listening to recordings at home to replace discomfort, ease anxiety, and increase energy. The control group will not receive the clinical hypnosis and serve as a comparison to the intervention group.

Inclusion Criteria

• All sexes, ages 12 to 18 years old at the time of enrollment
• Diagnosed with Crohn’s disease for at least 3 months before enrollment
• Disease activity determined by Improve Care Now Physician’s Global Assessment (ICN PGA) at most recent gastrointestinal (GI) clinic visit
• Able to speak, read, and write in English to understand the instructions of the hypnosis session, audio recordings, and surveys
• Can receive text messages or email, daily

Exclusion Criteria

• Adolescents under the age of 12 and over 18 years old
• Diagnosed with Crohn’s disease less than 3 months before enrollment
• Severe disease activity
• Not able to speak, read, and write in English to understand the instructions of the hypnosis session, audio recordings, and surveys
• Cannot receive text messages or email, daily

Locations

You may participate in this study at Vanderbilt University Medical Center in Nashville, Tennessee, United States, 37232. If you have any questions or concerns, feel free to contact Lynn Walker, PhD at lynn.walker@vumc.org.

Sponsors/Collaborators

This clinical trial is sponsored by Vanderbilt University Medical Center with Amanda D. Lee, MD as the Principal Investigator.